JP2022537553A5 - - Google Patents
Info
- Publication number
- JP2022537553A5 JP2022537553A5 JP2021575393A JP2021575393A JP2022537553A5 JP 2022537553 A5 JP2022537553 A5 JP 2022537553A5 JP 2021575393 A JP2021575393 A JP 2021575393A JP 2021575393 A JP2021575393 A JP 2021575393A JP 2022537553 A5 JP2022537553 A5 JP 2022537553A5
- Authority
- JP
- Japan
- Prior art keywords
- amino acid
- acid sequence
- seq
- sequence described
- item
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2025004808A JP2025061710A (ja) | 2019-06-20 | 2025-01-14 | Ｐｉｋ３ｃａ変異を標的にするｔ細胞レセプターおよびその使用 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962864148P | 2019-06-20 | 2019-06-20 | |
| US62/864,148 | 2019-06-20 | ||
| PCT/US2020/038592 WO2020257553A1 (en) | 2019-06-20 | 2020-06-19 | T cell receptors targeting pik3ca mutations and uses thereof |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025004808A Division JP2025061710A (ja) | 2019-06-20 | 2025-01-14 | Ｐｉｋ３ｃａ変異を標的にするｔ細胞レセプターおよびその使用 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022537553A JP2022537553A (ja) | 2022-08-26 |
| JP2022537553A5 true JP2022537553A5 (https=) | 2023-06-14 |
| JP7730298B2 JP7730298B2 (ja) | 2025-08-27 |
Family
ID=74040933
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021575393A Active JP7730298B2 (ja) | 2019-06-20 | 2020-06-19 | Ｐｉｋ３ｃａ変異を標的にするｔ細胞レセプターおよびその使用 |
| JP2025004808A Pending JP2025061710A (ja) | 2019-06-20 | 2025-01-14 | Ｐｉｋ３ｃａ変異を標的にするｔ細胞レセプターおよびその使用 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025004808A Pending JP2025061710A (ja) | 2019-06-20 | 2025-01-14 | Ｐｉｋ３ｃａ変異を標的にするｔ細胞レセプターおよびその使用 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US12492237B2 (https=) |
| EP (1) | EP3986450A4 (https=) |
| JP (2) | JP7730298B2 (https=) |
| CN (1) | CN114245745A (https=) |
| CA (1) | CA3144054A1 (https=) |
| WO (1) | WO2020257553A1 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2024220827A1 (en) * | 2023-04-21 | 2024-10-24 | Abata Therapeutics, Inc. | Cell therapies for type 1 diabetes |
| WO2025034618A1 (en) * | 2023-08-04 | 2025-02-13 | Vcreate, Inc. | A novel t-cell receptor and uses thereof |
| CN117736310B (zh) * | 2023-12-15 | 2025-03-18 | 重庆医科大学 | 一种hla-a1101限制性抗原表位肽、靶向表位肽tcr及其应用 |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5399346A (en) | 1989-06-14 | 1995-03-21 | The United States Of America As Represented By The Department Of Health And Human Services | Gene therapy |
| EP2052088A2 (en) | 2006-08-02 | 2009-04-29 | Genizon Biosciences | Genemap of the human genes associated with psoriasis |
| WO2008060510A2 (en) | 2006-11-13 | 2008-05-22 | Sangamo Biosciences, Inc. | Zinc finger nuclease for targeting the human glucocorticoid receptor locus |
| WO2009146179A1 (en) | 2008-04-15 | 2009-12-03 | University Of Iowa Research Foundation | Zinc finger nuclease for the cftr gene and methods of use thereof |
| CN102174576A (zh) | 2011-01-25 | 2011-09-07 | 西北农林科技大学 | 一种由锌指核酸酶介导的哺乳动物内源基因定向敲除的方法和该锌指核酸酶及其表达载体 |
| WO2013163628A2 (en) | 2012-04-27 | 2013-10-31 | Duke University | Genetic correction of mutated genes |
| CN103668470B (zh) | 2012-09-12 | 2015-07-29 | 上海斯丹赛生物技术有限公司 | 一种dna文库及构建转录激活子样效应因子核酸酶质粒的方法 |
| GB2508414A (en) | 2012-11-30 | 2014-06-04 | Max Delbrueck Centrum | Tumour specific T cell receptors (TCRs) |
| US8697359B1 (en) | 2012-12-12 | 2014-04-15 | The Broad Institute, Inc. | CRISPR-Cas systems and methods for altering expression of gene products |
| WO2014134412A1 (en) | 2013-03-01 | 2014-09-04 | Regents Of The University Of Minnesota | Talen-based gene correction |
| JP6712948B2 (ja) | 2013-12-12 | 2020-06-24 | ザ・ブロード・インスティテュート・インコーポレイテッド | 組成物、及びヌクレオチドリピート障害におけるｃｒｉｓｐｒ−ｃａｓ系の使用方法 |
| EP3690044B1 (en) | 2014-02-11 | 2024-01-10 | The Regents of the University of Colorado, a body corporate | Crispr enabled multiplexed genome engineering |
| MX375379B (es) * | 2014-05-29 | 2025-03-06 | Us Health | Receptores de celulas t anti - papilomavirus 16 e7 humano. |
| IL294183B2 (en) * | 2015-05-20 | 2023-10-01 | Dana Farber Cancer Inst Inc | shared neoantigens |
| GB201604494D0 (en) * | 2016-03-16 | 2016-04-27 | Immatics Biotechnologies Gmbh | Transfected T-Cells and T-Cell receptors for use in immunotherapy against cancers |
| GB201604492D0 (en) * | 2016-03-16 | 2016-04-27 | Immatics Biotechnologies Gmbh | Transfected t-cells and t-cell receptors for use in immunotherapy against cancers |
| DE102017106305A1 (de) | 2017-03-23 | 2018-09-27 | Immatics Biotechnologies Gmbh | Neue T-Zellrezeptoren und deren Verwendung in Immuntherapien gegen prame-positive Krebsarten |
| EP4252759B1 (en) * | 2018-05-11 | 2025-08-06 | Memorial Sloan Kettering Cancer Center | T cell receptors targeting pik3ca mutations and uses thereof |
-
2020
- 2020-06-19 CA CA3144054A patent/CA3144054A1/en active Pending
- 2020-06-19 WO PCT/US2020/038592 patent/WO2020257553A1/en not_active Ceased
- 2020-06-19 CN CN202080057384.4A patent/CN114245745A/zh active Pending
- 2020-06-19 JP JP2021575393A patent/JP7730298B2/ja active Active
- 2020-06-19 EP EP20827730.1A patent/EP3986450A4/en active Pending
-
2021
- 2021-12-17 US US17/555,007 patent/US12492237B2/en active Active
-
2025
- 2025-01-14 JP JP2025004808A patent/JP2025061710A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR20230079259A (ko) | Kras 돌연변이 특이적 t세포 수용체의 스크리닝 및 항종양 용도 | |
| EP0529023B1 (en) | Therapeutically useful peptides and peptides fragments | |
| AU2017371260C1 (en) | T cell receptors with improved pairing | |
| JP2024520427A5 (https=) | ||
| JP2022537553A5 (https=) | ||
| JP2023085527A5 (https=) | ||
| Gedde-Dahl III et al. | T-cell responses against products of oncogenes: generation and characterization of human T-cell clones specific for p21 ras-derived synthetic peptides | |
| JP2021500855A5 (https=) | ||
| CN116789792A (zh) | 免疫原性wt-1肽和其使用方法 | |
| JP2008537736A (ja) | 抗原特異的ｔ細胞の操作に有用な組換えｍｈｃ分子 | |
| JP2025131589A (ja) | 固形腫瘍を治療するための遺伝子操作しているγδ－Ｔ細胞及び遺伝子操作していないγδ－Ｔ細胞に関する組成物及び方法 | |
| JPH07509251A (ja) | ｐ５３ワクチン | |
| JP2024519614A5 (https=) | ||
| JP2021505190A5 (https=) | ||
| JP2023511274A5 (https=) | ||
| CN100408595C (zh) | Sars病毒hla-a2限制性表位多肽及其应用 | |
| CN1948333B (zh) | 一种新的hPEBP4蛋白来源的HLA-A2限制性表位多肽及其应用 | |
| CN102443056B (zh) | 表皮生长因子受体的外显子缺失变异体 | |
| JP5189593B2 (ja) | 無差別ＨＥＲ−２／ＮｅｕＣＤ４Ｔ細胞エピトープ | |
| JP2023052688A (ja) | 対合が改善されたｔ細胞受容体ｔ細胞 | |
| CN1948342B (zh) | 一种新的候选癌基因hRabJ来源的HLA-A2限制性表位多肽及其应用 | |
| CN101812126B (zh) | 一种新的hPEBP4蛋白来源的HLA-A2限制性表位多肽及其应用 | |
| EP4328239A1 (en) | Immunotherapeutics based on magea1-derived epitopes | |
| JP2025516465A5 (https=) | ||
| Vandenbark et al. | Human TCR as antigen: Homologies and potentially cross-reactive HLA-DR2-restricted epitopes within the AV and BV CDR2 loops |